logo-loader
AMEX:RNN

Rexahn Pharmaceuticals, Inc.

Receive alerts
Market:
AMEX
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Rexahn’s goal is to be a world-class biopharmaceutical company developing and delivering novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Leveraging a powerful, multi-faceted discovery engine consisting of small signaling molecule discovery, computational modeling and nanotechnology-based drug targeting and delivery, we believe that we are well on our way to achieving our goal.